Clinical and dosimetric aspects in concurrent radiotherapy with CDK4/6 inhibitors in breast cancer

被引：0
|
作者：
Rebegea, Laura Florentina [1 ,2 ,3 ]
Ilie, Ana Maria [1 ]
Anghel, Rodica [4 ]
Lungu, Mihaela [2 ,5 ]
Dumitru, Mihaela Emilia [1 ]
机构：
[1] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Radiotherapy, Galati 800578, Romania
[2] Univ Galatzi, Fac Med & Pharm, Dept Clin Med, Galati, Romania
[3] Univ Galatzi, Res Ctr Field Med & Pharmaceut Sci, ReFORM UDJ, Galati, Romania
[4] Carol Davila Univ Med & Pharm, Dept Clin Med, Bucharest, Romania
[5] Sfantul Apostol Andrei Emergency Clin Hosp, Dept Neurol, Galati 800578, Romania
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
radiotherapy; CDK4/6i; toxicities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2226
引用
收藏
页码：S632 / S633
页数：3
相关论文
共 50 条
  • [21] Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors
    Vanessa Klapp
    Aitziber Buqué
    Norma Bloy
    Ai Sato
    Takahiro Yamazaki
    Xi Kathy Zhou
    Silvia C. Formenti
    Lorenzo Galluzzi
    Giulia Petroni
    Journal of Translational Medicine, 21
  • [22] Concurrent Use of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors with Palliative Radiotherapy for Metastatic Breast Cancer Patients: A Review of Toxicity
    Sonmez, Ozlem
    Tezcanli, Evrim
    TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2021, 36 (04): : 538 - 542
  • [23] Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer
    Wang, Runtian
    Xu, Kun
    Gao, Fangyan
    Huang, Jinyi
    Guan, Xiaoxiang
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (02):
  • [24] CDK4/6 inhibitors in breast cancer - from in vitro models to clinical trials
    Saleh, Lubaid
    Wilson, Caroline
    Holen, Ingunn
    ACTA ONCOLOGICA, 2020, 59 (02) : 219 - 232
  • [25] CDK6 overexpression promotes resistance to CDK4/6 inhibitors in breast cancer
    Li, Qing
    Razavi, Pedram
    Li, Zhiqiang
    Paula, Arnaud F. Da Cruz
    Brogi, Edi
    Scaltriti, Maurizio
    Reis-Filho, Jorge S.
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Clinical development of CDK4/6 inhibitor for breast cancer
    Iwata, Hiroji
    BREAST CANCER, 2018, 25 (04) : 402 - 406
  • [27] Clinical development of CDK4/6 inhibitor for breast cancer
    Hiroji Iwata
    Breast Cancer, 2018, 25 : 402 - 406
  • [28] IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER
    Petroni, Giulia
    Gouin, Kenneth
    Martinez, Aitziber Buque
    Knott, Simon
    Formenti, Silvia
    Galluzzi, Lorenzo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A763 - A763
  • [29] Safety of CDK4/6 Inhibitors Combined with Radiotherapy in Patients with Metastatic Breast Cancer: A Review of the Literature
    Franco, Rejane
    Cao, Jeffrey Q.
    Yassa, Michael
    Hijal, Tarek
    CURRENT ONCOLOGY, 2023, 30 (06) : 5485 - 5496
  • [30] Position paper on CDK4/6 inhibitors in early breast cancer
    Michael Gnant
    Christian F. Singer
    Gabriel Rinnerthaler
    Georg Pfeiler
    Daniel Egle
    Marija Balic
    Rupert Bartsch
    memo - Magazine of European Medical Oncology, 2023, 16 : 135 - 144
12345